Korean College of Helicobacter and Upper Gastrointestinal Research

Today 2024.02.24 D-DAY -1072

Scientific Program

Program Details

  >  Scientific Program  >  Program Details

Distinct Poster Oral Presentation 1 Day 1_ 19(Fri.) 14:30 - 15:30 Room B

Nayoung Kim (Seoul National University, Korea) / Sang Kil Lee (Yonsei University, Korea)

14:30-14:40 PO-01 (Abstract No. A-0047)
Sun-young Lee (Konkuk University School Of Medicine, Korea)
Efficacy of seven-days bismuth-administered potassium-competitive acid blocker-based first-line Helicobacter pylori eradication therapy
14:40-14:50 PO-02 (Abstract No. A-0154)
Youn I Choi (Gachon University, Gil Medical Center, Korea)
Title: Tailored eradication strategy versus concomitant therapy as the first-line for Helicobacter pylori eradication treatment in Korean patients: A comparative study
14:50-15:00 PO-03 (Abstract No. A-0102)
Soo-young Na (Incheon St. Mary's Hospital, The Catholic University of Korea, Korea)
Effective eradication regimen and duration according to the results of clarithromycin susceptibility of Helicobacter pylori
15:00-15:10 PO-04 (Abstract No. A-0148)
Younghee Choe (Catholic University of Korea, Incheo, Korea)
A multicenter study on the past use of metronidazole and the success rate of Helicobacter pylori eradication
15:10-15:20 PO-05 (Abstract No. A-0042)
Muhammad Miftahussurur (Faculty of Medicine Universitas Airlangga, Indonesia)
The tlyA Helicobacter pylori genotype Associated with Bacterial Density
15:20-15:30 PO-06 (Abstract No. A-0090)
Yonghwan Kwon (Kyungpook National University Chilgok Hospital, Korea)
The Change of Immunological Markers in Helicobacter pylori Infection and Aging

Distinct Poster Oral Presentation 2 Day 1_ 19(Fri.) 14:30 - 15:30 Room C

Moo In Park (Kosin University, Korea) / Sung Woo Jung (Korea University, Korea)

14:30-14:40 PO-07 (Abstract No. A-0085)
Ilsoo Kim (Yeoui-do St.mary's Hospital, Korea)
The Effect of PPI pre-administration on Helicobacter pylori Eradication Success Rate
14:40-14:50 PO-08 (Abstract No. A-0067)
Jamal Houssaini (I-pperform, Universiti Teknologi Mara, Uitm (faculty of Medicine), Malaysia)
Molecular Characterisation and Expression Patterns of Toll-like Receptors (TLRs) associated H. pylori Infection: In vitro Study
14:50-15:00 PO-09 (Abstract No. A-0050)
Jung-wook Kim (Kyung Hee University Hospital, Korea)
Cost-effectiveness of empirical bismuth-based quadruple therapy and tailored therapy after clarithromycin resistance tests for Helicobacter pylori eradication
15:00-15:10 PO-10 (Abstract No. A-0038)
Hae Won Yoo (Soonchunhyang University, Bucheon Hospital, Korea)
Risk of metachronous gastric neoplasm after endoscopic submucosal dissection: a comparison between undifferentiated type and differentiated type
15:10-15:20 PO-11 (Abstract No. A-0041)
Jin Hee Noh (Asan Medical Center, Korea)
Scoring system for predicting clinical outcomes and endoscopic intervention requirement in peptic ulcer bleeding
15:20-15:30 PO-12 (Abstract No. A-0106)
Boram Cha (Inha University Hospital, Korea)
Clinical Outcomes of Rebleeding in Patients with Benign Peptic Ulcer Rebleeding after Emergency Endoscopy: A Retrospective Observational Study
Korean College of Helicobacter and Upper Gastrointestinal Research
Room 305, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
TEL: +82-2-565-9946 FAX: +82-2-565-9947 E-mail: hpylori@kams.or.kr
대한상부위장관∙헬리코박터학회 / 대표자:김재규 / 사업자번호:106-82-61000 / 주소 : 서울시 강남구 선릉로 86길 31, 305호 / 전화:02-565-9946
HUG 2021 Secretariat : MediOffice
Tel : +82-2-459-8252
Fax : +82-2-459-8256
Email: helicobacter@medioffice.or.kr